Tirzepatide

Overview

Tirzepatide is a synthetic research peptide that functions as a dual agonist for the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is actively studied in laboratory settings for its potential impact on metabolic pathways, glucose regulation, and weight control in preclinical models such as laboratory rodents.

Benefits

In controlled laboratory research, Tirzepatide has demonstrated the ability to support reduced food intake, improved glucose tolerance, and significant weight reduction in test subjects. Dual receptor agonists like Tirzepatide may offer greater metabolic benefits compared to single agonists, enhancing energy balance and body weight outcomes in research models.
Source: Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM, 2022. Link

Possible Side Effects

Test subjects administered Tirzepatide in laboratory studies have shown mild gastrointestinal effects such as reduced appetite, nausea-like responses, and slowed gastric emptying. Some observations also include mild injection site reactions and slight increases in resting heart rate in research animals.
Source: Jastreboff AM, et al., NEJM, 2022. Link

Dosage & Administration

Tirzepatide is administered via subcutaneous injection under strict laboratory protocols. Typical dosing for research ranges from 2.5 mg to 15 mg once per week, depending on the study design and the species being used. Frequency is generally once weekly for monitoring metabolic markers and weight changes in test models.
For laboratory research use only. Not for human consumption.

Summary

Tirzepatide is an advanced dual receptor agonist peptide designed for laboratory research on metabolic health and weight regulation in test subjects. Studies have shown its potential to reduce food intake and improve glucose metabolism, with mild gastrointestinal side effects observed in preclinical models. Tirzepatide is typically administered by subcutaneous injection once weekly, with dosage tailored to specific research protocols.
For research purposes only. Not for human use.